Myelofibrosis Post-essential Thrombocythemia
📧 Sign up to get email alerts when something new happens for Myelofibrosis Post-essential Thrombocythemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: INCB000928 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Anemia Due to Myeloproliferative Disorders [Phase 1, Phase 2]
Clinical trial update shows INCB000928 is being studied as a monotherapy or in combination with ruxolitinib for anemia due to myeloprolifera…
-
CLINICAL_TRIALS trial_result · 2025-03-05Clinical Trial Update: Phase 2 Study in Japanese Patients With Intermediate-2 or High Risk Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis With Splenomegaly [Phase 2]
Phase 2 study sponsored by Bristol-Myers Squibb in Japanese patients with intermediate-2 or high-risk primary myelofibrosis, post-polycythem…